long intergenic non-protein coding RNA 2067Genealiases: []
Q-omics provides the consensus-scored LINC02067 profile across patient tissues and cancer cell-line models. LINC02067 expression is associated with patient survival in 19 of 34 cancer types, with the highest sampling consensus in BLCA. Among the 18 cancer types available for tumor–normal comparison, LINC02067 is differentially expressed in 7, with the highest sampling consensus in KIRC. Additionally, LINC02067 RNA expression shows 7,526 significant gene co-expression associations, with the highest sampling consensus in BLCA. Together, these results highlight BLCA, and KIRC as cancer lineages where LINC02067 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02067 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02067 survival associations across molecular data types. LINC02067 RNA expression shows survival associations in the most cancer types (19). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02067 RNA expression–survival associations across cancer types. High LINC02067 expression shows unfavorable associations in LGG, READ, KIRC and KICH, but favorable associations in BLCA and KIRP. The BLCA Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify BLCA as the clearest survival context for LINC02067 RNA expression.
This table summarizes LINC02067 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 7. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02067. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02067 shows lower tumor expression in THCA and higher tumor expression in KIRC, BRCA, LUSC, LIHC and READ. The KIRC box plot shows higher LINC02067 RNA expression in tumor versus normal tissue (log2 FC = +0.069, t-test p < 0.001).
This table shows molecular features associated with LINC02067 in patient tissues and cancer cell lines. In patient samples, LINC02067 shows the broadest associations at the RNA and protein expression levels, with BLCA recurring as the lineage with the largest associated feature set.
